Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Monoclonal Antibody Therapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Johnson & Johnson
Novartis AG
Sanofi
Pfizer Inc
Bayer AG
GlaxoSmithKline Plc
F Hoffmann-La Roche Ltd
Merck KGaA
Bristol – Myers Squibb Company
GenScript
Sigma-Aldrich Co LLC
Biogen Inc
By Type:
Humanized
Human
Recombinant
Chimeric
By Application:
Diagnostic Test
Autoimmune Diseases
Cancer Treatment
Analytical and Chemical Uses
Hematological Disorders
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Monoclonal Antibody Therapy Market Overview 2018-2029
-
1.1 China Monoclonal Antibody Therapy Industry Development Overview
-
1.2 China Monoclonal Antibody Therapy Industry Development History
-
1.3 China Monoclonal Antibody Therapy Industry Market Size (2018-2029)
-
1.4 China Monoclonal Antibody Therapy Market Analysis by Type from Production Side
-
1.4.1 China Monoclonal Antibody Therapy Production Volume, Production Value and Growth Rate of Humanized (2018-2029)
-
1.4.2 China Monoclonal Antibody Therapy Production Volume, Production Value and Growth Rate of Human (2018-2029)
-
1.4.3 China Monoclonal Antibody Therapy Production Volume, Production Value and Growth Rate of Recombinant (2018-2029)
-
1.4.4 China Monoclonal Antibody Therapy Production Volume, Production Value and Growth Rate of Chimeric (2018-2029)
-
1.5 China Monoclonal Antibody Therapy Market Analysis by Application from Consumption End
-
1.5.1 China Monoclonal Antibody Therapy Sales Volume, Sales Value and Growth Rate of Diagnostic Test (2018-2029)
-
1.5.2 China Monoclonal Antibody Therapy Sales Volume, Sales Value and Growth Rate of Autoimmune Diseases (2018-2029)
-
1.5.3 China Monoclonal Antibody Therapy Sales Volume, Sales Value and Growth Rate of Cancer Treatment (2018-2029)
-
1.5.4 China Monoclonal Antibody Therapy Sales Volume, Sales Value and Growth Rate of Analytical and Chemical Uses (2018-2029)
-
1.5.5 China Monoclonal Antibody Therapy Sales Volume, Sales Value and Growth Rate of Hematological Disorders (2018-2029)
-
1.6 China Monoclonal Antibody Therapy Market Analysis by Region
-
1.6.1 North China Monoclonal Antibody Therapy Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Monoclonal Antibody Therapy Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Monoclonal Antibody Therapy Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Monoclonal Antibody Therapy Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Monoclonal Antibody Therapy Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Monoclonal Antibody Therapy Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Monoclonal Antibody Therapy Market Size and Growth Rate from 2018-2029
Chapter 2 China Monoclonal Antibody Therapy Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Monoclonal Antibody Therapy Market Status and Competition at home and abroad in 2023
-
2.2.2 China Monoclonal Antibody Therapy Market Status and Competition Analysis in 2023
-
2.2.3 China Monoclonal Antibody Therapy Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Monoclonal Antibody Therapy Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Monoclonal Antibody Therapy Industry Development
Chapter 3 Monoclonal Antibody TherapyIndustry Chain Analysis
-
3.1 Monoclonal Antibody Therapy Industry Chain
-
3.2 Monoclonal Antibody Therapy Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Monoclonal Antibody Therapy Market
-
3.3 Monoclonal Antibody Therapy Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Monoclonal Antibody Therapy Market
Chapter 4 China Monoclonal Antibody Therapy Market, by Type
-
4.1 China Monoclonal Antibody Therapy Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Monoclonal Antibody Therapy Total Production Volume and Growth Rate from Production Side
-
4.5 China Monoclonal Antibody Therapy Production Volume and Growth Rate, by Type
-
4.5.1 China Monoclonal Antibody Therapy Production Volume and Growth Rate of Humanized
-
4.5.2 China Monoclonal Antibody Therapy Production Volume and Growth Rate of Human
-
4.5.3 China Monoclonal Antibody Therapy Production Volume and Growth Rate of Recombinant
-
4.5.4 China Monoclonal Antibody Therapy Production Volume and Growth Rate of Chimeric
Chapter 5 China Monoclonal Antibody Therapy Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Monoclonal Antibody Therapy Total Market Size and Growth Rate from Consumption End
-
5.5 China Monoclonal Antibody Therapy Market Size and Growth Rate, by Application
-
5.5.1 China Monoclonal Antibody Therapy Market Size and Growth Rate of Diagnostic Test
-
5.5.2 China Monoclonal Antibody Therapy Market Size and Growth Rate of Autoimmune Diseases
-
5.5.3 China Monoclonal Antibody Therapy Market Size and Growth Rate of Cancer Treatment
-
5.5.4 China Monoclonal Antibody Therapy Market Size and Growth Rate of Analytical and Chemical Uses
-
5.5.5 China Monoclonal Antibody Therapy Market Size and Growth Rate of Hematological Disorders
Chapter 6 China Monoclonal Antibody Therapy Market, by Region
-
6.1 China Monoclonal Antibody Therapy Production Volume and Production Value, by Region
-
6.2 China Monoclonal Antibody Therapy Sales Volume and Sales Value, by Region
Chapter 7 North China Monoclonal Antibody Therapy Market Analysis
-
7.1 North China Monoclonal Antibody Therapy Market, by Type
-
7.2 North China Monoclonal Antibody Therapy Market, by Application
Chapter 8 Central China Monoclonal Antibody Therapy Market Analysis
-
8.1 Central China Monoclonal Antibody Therapy Market, by Type
-
8.2 Central China Monoclonal Antibody Therapy Market, by Application
Chapter 9 South China Monoclonal Antibody Therapy Market Analysis
-
9.1 South China Monoclonal Antibody Therapy Market, by Type
-
9.2 South China Monoclonal Antibody Therapy Market, by Application
Chapter 10 East China Monoclonal Antibody Therapy Market Analysis
-
10.1 East China Monoclonal Antibody Therapy Market, by Type
-
10.2 East China Monoclonal Antibody Therapy Market, by Application
Chapter 11 Northeast China Monoclonal Antibody Therapy Market Analysis
-
11.1 Northeast China Monoclonal Antibody Therapy Market, by Type
-
11.2 Northeast China Monoclonal Antibody Therapy Market, by Application
Chapter 12 Southwest China Monoclonal Antibody Therapy Market Analysis
-
12.1 Southwest China Monoclonal Antibody Therapy Market, by Type
-
12.2 Southwest China Monoclonal Antibody Therapy Market, by Application
Chapter 13 Northwest China Monoclonal Antibody Therapy Market Analysis
-
13.1 Northwest China Monoclonal Antibody Therapy Market, by Type
-
13.2 Northwest China Monoclonal Antibody Therapy Market, by Application
Chapter 14 Company Profiles
-
14.1 Johnson & Johnson
-
14.1.1 Johnson & Johnson Company Profile
-
14.1.2 Johnson & Johnson Monoclonal Antibody Therapy Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Novartis AG
-
14.2.1 Novartis AG Company Profile
-
14.2.2 Novartis AG Monoclonal Antibody Therapy Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Sanofi
-
14.3.1 Sanofi Company Profile
-
14.3.2 Sanofi Monoclonal Antibody Therapy Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Pfizer Inc
-
14.4.1 Pfizer Inc Company Profile
-
14.4.2 Pfizer Inc Monoclonal Antibody Therapy Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Bayer AG
-
14.5.1 Bayer AG Company Profile
-
14.5.2 Bayer AG Monoclonal Antibody Therapy Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 GlaxoSmithKline Plc
-
14.6.1 GlaxoSmithKline Plc Company Profile
-
14.6.2 GlaxoSmithKline Plc Monoclonal Antibody Therapy Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 F Hoffmann-La Roche Ltd
-
14.7.1 F Hoffmann-La Roche Ltd Company Profile
-
14.7.2 F Hoffmann-La Roche Ltd Monoclonal Antibody Therapy Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Merck KGaA
-
14.8.1 Merck KGaA Company Profile
-
14.8.2 Merck KGaA Monoclonal Antibody Therapy Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Bristol – Myers Squibb Company
-
14.9.1 Bristol – Myers Squibb Company Company Profile
-
14.9.2 Bristol – Myers Squibb Company Monoclonal Antibody Therapy Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 GenScript
-
14.10.1 GenScript Company Profile
-
14.10.2 GenScript Monoclonal Antibody Therapy Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Sigma-Aldrich Co LLC
-
14.11.1 Sigma-Aldrich Co LLC Company Profile
-
14.11.2 Sigma-Aldrich Co LLC Monoclonal Antibody Therapy Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Biogen Inc
-
14.12.1 Biogen Inc Company Profile
-
14.12.2 Biogen Inc Monoclonal Antibody Therapy Market Performance
-
14.12.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Monoclonal Antibody Therapy Industry Research Conclusions
-
15.2 Monoclonal Antibody Therapy Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Monoclonal Antibody Therapy Industry Market Size (2018-2029)
-
Figure China Monoclonal Antibody Therapy Production Volume, Production Value and Growth Rate of Humanized (2018-2029)
-
Figure China Monoclonal Antibody Therapy Production Volume, Production Value and Growth Rate of Human (2018-2029)
-
Figure China Monoclonal Antibody Therapy Production Volume, Production Value and Growth Rate of Recombinant (2018-2029)
-
Figure China Monoclonal Antibody Therapy Production Volume, Production Value and Growth Rate of Chimeric (2018-2029)
-
Figure China Monoclonal Antibody Therapy Sales Volume, Sales Value and Growth Rate of Diagnostic Test (2018-2029)
-
Figure China Monoclonal Antibody Therapy Sales Volume, Sales Value and Growth Rate of Autoimmune Diseases (2018-2029)
-
Figure China Monoclonal Antibody Therapy Sales Volume, Sales Value and Growth Rate of Cancer Treatment (2018-2029)
-
Figure China Monoclonal Antibody Therapy Sales Volume, Sales Value and Growth Rate of Analytical and Chemical Uses (2018-2029)
-
Figure China Monoclonal Antibody Therapy Sales Volume, Sales Value and Growth Rate of Hematological Disorders (2018-2029)
-
Figure North China Monoclonal Antibody Therapy Market Size and Growth Rate from 2018-2029
-
Figure Central China Monoclonal Antibody Therapy Market Size and Growth Rate from 2018-2029
-
Figure South China Monoclonal Antibody Therapy Market Size and Growth Rate from 2018-2029
-
Figure East China Monoclonal Antibody Therapy Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Monoclonal Antibody Therapy Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Monoclonal Antibody Therapy Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Monoclonal Antibody Therapy Market Size and Growth Rate from 2018-2029
-
Figure Monoclonal Antibody Therapy Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Monoclonal Antibody Therapy Market Share by Type in 2018
-
Figure China Monoclonal Antibody Therapy Market Share by Type in 2023
-
Figure China Monoclonal Antibody Therapy Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Monoclonal Antibody Therapy Production Volume and Growth Rate of Humanized (2018-2023)
-
Figure China Monoclonal Antibody Therapy Production Volume and Growth Rate of Human (2018-2023)
-
Figure China Monoclonal Antibody Therapy Production Volume and Growth Rate of Recombinant (2018-2023)
-
Figure China Monoclonal Antibody Therapy Production Volume and Growth Rate of Chimeric (2018-2023)
-
Figure China Monoclonal Antibody Therapy Market Share by Application in 2018
-
Figure China Monoclonal Antibody Therapy Market Share by Application in 2023
-
Figure China Monoclonal Antibody Therapy Total Market Size and Growth Rate from Consumption End
-
Figure China Monoclonal Antibody Therapy Market Size and Growth Rate of Diagnostic Test (2018-2023)
-
Figure China Monoclonal Antibody Therapy Market Size and Growth Rate of Autoimmune Diseases (2018-2023)
-
Figure China Monoclonal Antibody Therapy Market Size and Growth Rate of Cancer Treatment (2018-2023)
-
Figure China Monoclonal Antibody Therapy Market Size and Growth Rate of Analytical and Chemical Uses (2018-2023)
-
Figure China Monoclonal Antibody Therapy Market Size and Growth Rate of Hematological Disorders (2018-2023)
-
Table China Monoclonal Antibody Therapy Production Volume by Region (2018-2023)
-
Table China Monoclonal Antibody Therapy Production Volume Share by Region (2018-2023)
-
Figure China Monoclonal Antibody Therapy Production Volume Share by Region (2018-2023)
-
Table China Monoclonal Antibody Therapy Production Value by Region (2018-2023)
-
Table China Monoclonal Antibody Therapy Production Value Share by Region (2018-2023)
-
Figure China Monoclonal Antibody Therapy Production Value Share by Region (2018-2023)
-
Table China Monoclonal Antibody Therapy Sales Volume by Region (2018-2023)
-
Table China Monoclonal Antibody Therapy Sales Volume Share by Region (2018-2023)
-
Figure China Monoclonal Antibody Therapy Sales Volume Share by Region (2018-2023)
-
Table China Monoclonal Antibody Therapy Sales Value by Region (2018-2023)
-
Table China Monoclonal Antibody Therapy Sales Value Share by Region (2018-2023)
-
Figure China Monoclonal Antibody Therapy Sales Value Share by Region (2018-2023)
-
Table North China Monoclonal Antibody Therapy Production Volume by Type (2018-2023)
-
Table North China Monoclonal Antibody Therapy Production Volume Share by Type (2018-2023)
-
Figure North China Monoclonal Antibody Therapy Production Volume Share by Type (2018-2023)
-
Table North China Monoclonal Antibody Therapy Sales Volume by Application (2018-2023)
-
Table North China Monoclonal Antibody Therapy Sales Volume Share by Application (2018-2023)
-
Figure North China Monoclonal Antibody Therapy Sales Volume Share by Application (2018-2023)
-
Table Central China Monoclonal Antibody Therapy Production Volume by Type (2018-2023)
-
Table Central China Monoclonal Antibody Therapy Production Volume Share by Type (2018-2023)
-
Figure Central China Monoclonal Antibody Therapy Production Volume Share by Type (2018-2023)
-
Table Central China Monoclonal Antibody Therapy Sales Volume by Application (2018-2023)
-
Table Central China Monoclonal Antibody Therapy Sales Volume Share by Application (2018-2023)
-
Figure Central China Monoclonal Antibody Therapy Sales Volume Share by Application (2018-2023)
-
Table South China Monoclonal Antibody Therapy Production Volume by Type (2018-2023)
-
Table South China Monoclonal Antibody Therapy Production Volume Share by Type (2018-2023)
-
Figure South China Monoclonal Antibody Therapy Production Volume Share by Type (2018-2023)
-
Table South China Monoclonal Antibody Therapy Sales Volume by Application (2018-2023)
-
Table South China Monoclonal Antibody Therapy Sales Volume Share by Application (2018-2023)
-
Figure South China Monoclonal Antibody Therapy Sales Volume Share by Application (2018-2023)
-
Table East China Monoclonal Antibody Therapy Production Volume by Type (2018-2023)
-
Table East China Monoclonal Antibody Therapy Production Volume Share by Type (2018-2023)
-
Figure East China Monoclonal Antibody Therapy Production Volume Share by Type (2018-2023)
-
Table East China Monoclonal Antibody Therapy Sales Volume by Application (2018-2023)
-
Table East China Monoclonal Antibody Therapy Sales Volume Share by Application (2018-2023)
-
Figure East China Monoclonal Antibody Therapy Sales Volume Share by Application (2018-2023)
-
Table Northeast China Monoclonal Antibody Therapy Production Volume by Type (2018-2023)
-
Table Northeast China Monoclonal Antibody Therapy Production Volume Share by Type (2018-2023)
-
Figure Northeast China Monoclonal Antibody Therapy Production Volume Share by Type (2018-2023)
-
Table Northeast China Monoclonal Antibody Therapy Sales Volume by Application (2018-2023)
-
Table Northeast China Monoclonal Antibody Therapy Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Monoclonal Antibody Therapy Sales Volume Share by Application (2018-2023)
-
Table Southwest China Monoclonal Antibody Therapy Production Volume by Type (2018-2023)
-
Table Southwest China Monoclonal Antibody Therapy Production Volume Share by Type (2018-2023)
-
Figure Southwest China Monoclonal Antibody Therapy Production Volume Share by Type (2018-2023)
-
Table Southwest China Monoclonal Antibody Therapy Sales Volume by Application (2018-2023)
-
Table Southwest China Monoclonal Antibody Therapy Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Monoclonal Antibody Therapy Sales Volume Share by Application (2018-2023)
-
Table Northwest China Monoclonal Antibody Therapy Production Volume by Type (2018-2023)
-
Table Northwest China Monoclonal Antibody Therapy Production Volume Share by Type (2018-2023)
-
Figure Northwest China Monoclonal Antibody Therapy Production Volume Share by Type (2018-2023)
-
Table Northwest China Monoclonal Antibody Therapy Sales Volume by Application (2018-2023)
-
Table Northwest China Monoclonal Antibody Therapy Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Monoclonal Antibody Therapy Sales Volume Share by Application (2018-2023)
-
Table Johnson & Johnson Company Profile
-
Table Johnson & Johnson Monoclonal Antibody Therapy Revenue, Price and Gross (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG Monoclonal Antibody Therapy Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Monoclonal Antibody Therapy Revenue, Price and Gross (2018-2023)
-
Table Pfizer Inc Company Profile
-
Table Pfizer Inc Monoclonal Antibody Therapy Revenue, Price and Gross (2018-2023)
-
Table Bayer AG Company Profile
-
Table Bayer AG Monoclonal Antibody Therapy Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Plc Company Profile
-
Table GlaxoSmithKline Plc Monoclonal Antibody Therapy Revenue, Price and Gross (2018-2023)
-
Table F Hoffmann-La Roche Ltd Company Profile
-
Table F Hoffmann-La Roche Ltd Monoclonal Antibody Therapy Revenue, Price and Gross (2018-2023)
-
Table Merck KGaA Company Profile
-
Table Merck KGaA Monoclonal Antibody Therapy Revenue, Price and Gross (2018-2023)
-
Table Bristol – Myers Squibb Company Company Profile
-
Table Bristol – Myers Squibb Company Monoclonal Antibody Therapy Revenue, Price and Gross (2018-2023)
-
Table GenScript Company Profile
-
Table GenScript Monoclonal Antibody Therapy Revenue, Price and Gross (2018-2023)
-
Table Sigma-Aldrich Co LLC Company Profile
-
Table Sigma-Aldrich Co LLC Monoclonal Antibody Therapy Revenue, Price and Gross (2018-2023)
-
Table Biogen Inc Company Profile
-
Table Biogen Inc Monoclonal Antibody Therapy Revenue, Price and Gross (2018-2023)
-
